Lenvima 4mg Tablet (Lenvatinib)
Medicine OverView
Lenvima 4mg Tablet (Lenvatinib) is a targeted anti-cancer medicine used in the treatment of various advanced cancers including thyroid cancer, liver cancer, kidney cancer, and endometrial cancer. It contains Lenvatinib 4mg, a multi-kinase inhibitor that helps block tumor growth and reduce the blood supply required for cancer progression.
Lenvatinib works by targeting specific proteins and signaling pathways involved in cancer cell growth and angiogenesis (formation of new blood vessels). By inhibiting these pathways, Lenvima 4mg Tablet helps slow tumor progression and supports targeted oncology treatment outcomes.
Lenvima 4mg Tablet is commonly prescribed under specialist oncology supervision either alone or in combination with other anti-cancer medicines depending on the cancer type and patient condition.
This medicine should only be used under the guidance of qualified oncologists with regular laboratory and clinical monitoring.
Lenvima 4mg Tablet is used in the treatment and management of several advanced cancers.
Doctors may prescribe Lenvima 4mg Tablet as part of a personalized oncology treatment protocol.
Lenvima 4mg Tablet contains Lenvatinib, a targeted tyrosine kinase inhibitor.
Lenvatinib works by:
By reducing tumor blood supply and inhibiting cancer growth pathways, Lenvatinib helps control disease progression in certain cancers.
Lenvima 4mg Tablet offers several important benefits in advanced cancer management.
Targeted therapies help improve treatment precision and support modern oncology care approaches.
Targeted cancer therapies focus on blocking specific proteins and signaling pathways involved in tumor growth and progression.
Unlike conventional chemotherapy, targeted therapies aim to:
Lenvima 4mg Tablet helps inhibit angiogenesis and tumor growth pathways responsible for cancer progression.
The dosage of Lenvima 4mg Tablet depends on:
Important usage instructions:
Strict adherence to oncology treatment schedules improves therapeutic effectiveness.
Like all anti-cancer medicines, Lenvima 4mg Tablet may cause side effects in some patients.
Seek immediate medical attention if you experience:
Regular blood pressure checks and laboratory monitoring are important during treatment.
Before using Lenvima 4mg Tablet, inform your doctor if you have:
Regular blood pressure monitoring and laboratory tests may be required during therapy.
Avoid pregnancy during treatment unless advised otherwise by your healthcare provider.
Lenvima 4mg Tablet may interact with several medicines.
Always inform your oncologist about all medicines, supplements, and herbal products you are using.
Pregnancy: Lenvima 4mg Tablet may harm the unborn baby and should only be used if specifically advised by a specialist.
Breastfeeding: Breastfeeding is generally not recommended during treatment with Lenvatinib.
Discuss contraception and reproductive safety measures with your healthcare provider before starting treatment.
Lenvima 4mg Tablet is used for thyroid cancer, liver cancer, kidney cancer, and certain advanced cancers.
It contains Lenvatinib 4mg.
It works by blocking tumor growth signals and reducing blood supply to cancer cells.
Lenvima 4mg Tablet is a targeted anti-cancer therapy classified as a tyrosine kinase inhibitor.
Yes, it is commonly used in the management of certain advanced-stage cancers under oncology supervision.
Yes, Lenvima 4mg Tablet should only be used under specialist oncology supervision with a valid prescription.
You can buy Lenvima 4mg Tablet (Lenvatinib) online from a licensed oncology pharmacy with a valid prescription. Always purchase anti-cancer medicines from trusted suppliers to ensure product authenticity, quality, and proper storage conditions.
Before purchasing online:
What do you think about this product?